๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Individual dosing of carboplatin based on drug monitoring in children receiving high-dose chemotherapy

โœ Scribed by H. Rubie; F. Doz; G. Vassal; P. Chastagner; J-C. Gentet; S. Urien; G. Bastian; L. Drouard-Troalen; M. Barberi-Heyob; J. Catalin; E. Chatelut

Book ID
117660076
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
206 KB
Volume
39
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Hearing loss in children with brain tumo
Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue
โœ Freilich, Ronnie J.; Kraus, Dennis H.; Budnick, Amy S.; Bayer, Lisa A.; Finlay, ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 602 KB

Carboplatin is less ototoxic than cisplatin, but ototoxicity may occur with carboplatin at higher doses. We evaluated hearing in children with brain tumors treated with conventional dose cisplatin followed by highdose carboplatin. Children under 6 years of age, newly diagnosed with brain tumors, wer

Vascular events in patients receiving hi
Vascular events in patients receiving high-dose infusional 5-fluorouracil-based chemotherapy: The University of Chicago experience
โœ Gradishar, W. ;Vokes, E. ;Schilsky, R. ;Weichselbaum, R. ;Panje, W. ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 822 KB

In a retrospective review, 22 of a total of 244 patients (9%) patients with head and neck or gastrointestinal cancer who were treated with infusional 5-fluorouracil (5-FU)-based chemotherapy regimens experienced thrombotic vascular events. These events occurred concurrently with treatment or several